Skip to main content
Year archive

INVEX THERAPEUTICS LTD — 2021 filings

All 41 regulatory filings released by INVEX THERAPEUTICS LTD (IXC) in 2021, sourced directly from the official regulator.

41 Filings
2021 Period
2021 filings (41)
Filing Released Lang
UK R&D Tax Rebate 2 pages 192.9KB
Regulatory Filings
2021-12-19 English
Appointment IIH EVOLVE Phase III Trial Steering Group Chair 3 pages 191.5KB
Regulatory Filings
2021-12-16 English
Chairman's Address to Shareholders at AGM 6 pages 229.5KB
Regulatory Filings
2021-11-24 English
Results of Meeting 5 pages 241.4KB
Regulatory Filings
2021-11-24 English
Withdrawal of AGM Resolutions 2 pages 186.3KB
Regulatory Filings
2021-11-22 English
Invex to Present at Bell Potter Healthcare Conference 27 pages 873.1KB
Regulatory Filings
2021-11-09 English
Global Phase 3 Trial of Presendin to Launch in Q4 2021 5 pages 273.6KB
Regulatory Filings
2021-11-03 English
Notice of Webinar & Investor Presentation 23 pages 745.0KB
Regulatory Filings
2021-11-03 English
Notice of Annual General Meeting/Proxy Form 44 pages 2.2MB
Regulatory Filings
2021-10-24 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 432.1KB
Regulatory Filings
2021-10-19 English
Presentation at EANS 2021 Congress 2 pages 227.7KB
Regulatory Filings
2021-10-07 English
Date of AGM and Closing Date for Director Nominations 1
Regulatory Filings
2021-09-29 English
Exclusive Collaboration and Manufacturing Agreement 3 pages 203.2KB
Regulatory Filings
2021-09-26 English
Notice of Investor Call and Presentation 16 pages 761.8KB
Regulatory Filings
2021-09-26 English
Trading Halt 2 pages 556.0KB
Regulatory Filings
2021-09-23 English
Appendix 4E and Annual Report 58 pages 15.0MB
Regulatory Filings
2021-08-26 English
Appendix 4G 13 pages 317.8KB
Regulatory Filings
2021-08-26 English
Corporate Governance Statement 16 pages 364.9KB
Regulatory Filings
2021-08-26 English
Invex Granted Key European Patent for Exenatide 2 pages 186.1KB
Regulatory Filings
2021-08-15 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 509.0KB
Regulatory Filings
2021-07-22 English
Appendix 2A 21 pages 486.0KB
Regulatory Filings
2021-07-04 English
Notice of Upcoming Release of Securities from Escrow 1
Regulatory Filings
2021-06-22 English
Investor Presentation 16 pages 804.9KB
Regulatory Filings
2021-06-20 English
Invex Receives Written Response from FDA on Type C Meeting 3 pages 190.9KB
Regulatory Filings
2021-06-14 English
Formulation and Manufacturing Update 2 pages 185.8KB
Regulatory Filings
2021-05-06 English
Invex Granted Type C Meeting with FDA 2 pages 183.9KB
Regulatory Filings
2021-04-21 English
Appendix 4C - quarterly 10 pages 519.6KB
Regulatory Filings
2021-04-12 English
Change of Director's Interest Notice 2 pages 242.8KB
Regulatory Filings
2021-04-08 English
Appendix 3G 16 pages 264.7KB
Regulatory Filings
2021-04-08 English
Chairman's Address to Shareholders 3 pages 203.9KB
Regulatory Filings
2021-04-07 English
Results of Meeting 2 pages 207.8KB
Regulatory Filings
2021-04-07 English
Invex Files Pre-IND/Type B Meeting Request with US FDA 2 pages 187.3KB
Regulatory Filings
2021-03-30 English
Investor Presentation 17 pages 958.6KB
Regulatory Filings
2021-03-17 English
Invex to Present at Upcoming Small Caps Conference 1
Regulatory Filings
2021-03-14 English
Notice of General Meeting/Proxy Form 16 pages 912.3KB
Regulatory Filings
2021-03-07 English
Postcard to Shareholders 3 pages 193.1KB
Regulatory Filings
2021-03-07 English
US Trademark Granted for Presendin 2 pages 183.3KB
Regulatory Filings
2021-02-25 English
Invex Appoints Dr Megan Baldwin as Non-Executive Director 2 pages 191.1KB
Regulatory Filings
2021-02-15 English
Initial Director's Interest Notice 2 pages 240.1KB
Regulatory Filings
2021-02-15 English
Half Yearly Report and Accounts 21 pages 1.2MB
Regulatory Filings
2021-02-14 English
Appendix 4C - quarterly 10 pages 520.9KB
Regulatory Filings
2021-01-10 English